[Skip to Content]
Access to paid content on this site is currently suspended due to excessive activity being detected from your IP address Please contact the publisher to request reinstatement.
Sign In
Individual Sign In
Create an Account
Institutional Sign In
OpenAthens Shibboleth
[Skip to Content Landing]
January 1971

Response of Mesenteric Blood Flow to GlucagonInfluence of Pharmacological Stimulation and Blockade of Adrenergic Receptors

Author Affiliations

From the Department of Surgery, State University of New York at Buffalo, and the Surgical Research Laboratory, Edward J. Meyer Memorial Hospital, Buffalo.

Arch Surg. 1971;102(1):65-70. doi:10.1001/archsurg.1971.01350010067017

The influence of pharmacological stimulation and blockade of adrenergic receptors on the mesenteric blood flow response to glucagon was studied in anesthetized dogs. Electromagnetic flowmeter was used for recording of the superior mesenteric artery flow. The vasodilatory effect of glucagon was not blocked by dichloroisoproterenol. Vasoconstriction produced by the alpha-adrenergic agonist phenylephrine (neo-synephrine) hydrochloride was abolished in the splanchnic vascular bed by glucagon whether the hormone was administered before or during the phenylephrine infusion. The vasodilatory effect of phenoxybenzamine hydrochloride (Dibenzyline) was potentiated by glucagon selectively in the mesenteric region. It is concluded that the vasodilatory effect of glucagon on the mesentric vascular bed does not seem to be mediated via alpha-receptor blockade nor via stimulation of beta-receptors.

Kock NG, Tibblin S, Schenk WG Jr:  Hemodynamic responses to glucagon: An experimental study of central, visceral and peripheral effects . Ann Surg 171:373-379, 1970.Article
Tibblin S, Kock NG, Schenk WG Jr:  Splanchnic hemodynamic responses to glucagon . Arch Surg 100:84-89, 1970.Article
Shoemaker WC, VanItallie TB, Walker WF:  Measurement of hepatic glucose output and hepatic blood flow in response to glucagon . Amer J Physiol 196:315-318, 1959.
Tibblin S, Kock NG, Schenk WG Jr:  Dissociation of the hyperglucemic and vascular effects of glucagon . Surgery 67:816-825, 1970.
Kock NG, Tibblin S, Schenk WG Jr:  Mesenteric blood flow response to glucagon during temporary exclusion of the liver . Arch Surg 100:280-283, 1970.Article
Kock NG, Tibblin S, Schenk WG Jr: Modification by glucagon of the splanchnic vascular responses to activation of the sympathicoadrenal system. J Surg Res, to be published.
Schenk WG Jr, Dedichen H:  Electronic measurement of blood flow . Amer J Surg 114:111-118, 1967.Article
Glick G, Parmley WW, Wechsler AS, et al:  Glucagon: Its enhancement of cardiac performance in the cat and dog and persistance of its inotropic action despite beta receptor blockade with propranolol . Circ Res 22:789-799, 1968.Article
Whitsitt LS, Lucchesi BR:  Effects of beta receptor blockade and glucagon on the atrio-ventricular transmission system in the dog . Circ Res 23:585-595, 1968.Article
Ahlqvist R:  Agents which block adrenergic beta-receptors . Ann Rev Pharmacol 8:259-272, 1968.Article
Abe K, Robinson GA, Liddle GW, et al:  Role of cyclic AMP in mediating the effects of MSH, norepinephrine and melatonin on frog skin color . Endocrinology 85:674-679, 1969.Article
Robinson CA, Butcher RW, Sutherland EW:  Adenyl cyclase as adrenergic receptor . Ann NY Acad Sci 139:703-723, 1969.Article
Foa PP:  Glucagon . Ergebn Physiol 60:141-219, 1968.
Levey GS, Epstein SE:  Activation of adenyl cyclase by glucagon in cat and human heart . Circ Res 24:151-156, 1969.Article
Murad F, Vaughan M:  Effect of glucagon on rat heart adenyl cyclase . Biochem Pharmacol 18:1035-1590, 1969.Article